Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Metastatic Castration-resistant Prostate Cancer
Related studies linked through entity extraction aliases.
177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- NA
177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers
- Status
- TERMINATED
- Phase
- PHASE2
177Lu-HTK03170 in mCRPC With PSMA Positive Disease
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
Total Body PET-CT Imaging of Prostate Cancer Using Illuccix
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Phase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Status
- UNKNOWN
- Phase
- PHASE1
EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Status
- RECRUITING
- Phase
- PHASE1
A Study of TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Status
- RECRUITING
- Phase
- PHASE2
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Pamiparib in mCRPC With HRD or BRCA1/2 Mutation
- Status
- UNKNOWN
- Phase
- PHASE2